Cite

HARVARD Citation

    Yu, P. et al. (2019). Challenges in assessing the clinical utility and economic value of immune checkpoint inhibitor therapies of Cancer. Journal for immunotherapy of cancer. 7 (1), p. . [Online]. 
  
Back to record